Frequency analysis of the CCR5Δ32 mutation in patients with brucellosis

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 12, 2002, Pages 944-946

  Skendros, Panagiotis ^a   Boura, Panagiota ^a   Tsantas, Nikolaos ^a   Debre, Patrice ^b   Theodorou, Ioannis ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADOLESCENT; ADULT; AGED; ARTICLE; BRUCELLOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREQUENCY ANALYSIS; GENE MUTATION; GENOTYPE; GREECE; HOMOZYGOSITY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; VOLUNTEER; ALLELE; BRUCELLA; GENE FREQUENCY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADOLESCENT; AGED; ALLELES; BASE SEQUENCE; BRUCELLA; BRUCELLOSIS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MUTATION; RECEPTORS, CCR5;

EID: 0036883381     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000026975     Document Type: Article

References (18)

1. Schaible UE, Collins HL, Kaufmann SH. Confrontation between intracellular bacteria and the immune system. Adv Immunol 1999; 71: 267-377.
2. Boschiroli M, Foulongne V, O'Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol 2001; 4: 58-64.
3. Golding B, Scott DE, Scharf O, et al. Immunity and protection against Brucella abortus. Microb Infect 2001; 3: 43-8.
4. + T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-in-activated Brucella abortus. Infect Immun 1995; 63: 2720-8.
5. Boura P, Skendros P, Kountouras J, Zacharioudaki E, Tsapas G. Effect of bacterial extracts on the immunologic profile in chronic relapsing brucellosis patients. Int J Immunopathol Pharmacol 1999; 12: 103-11.
6. Bellamy R, Hill AVS. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr Opin Immunol 1998; 10: 483-7.
7. Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol 2000; 121: 480-3.
8. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokines receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19: 568-74.
9. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-73.
10. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-5.
11. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856-62.
12. Liautard JP, Gross A, Dornand J, Kohler S. Interactions between professional phagocytes and Brucella spp. Microbiologia 1996; 12: 197-206.
13. Zaitseva M, King LR, Manischewitz J, et al. Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1 alpha and 1 beta following stimulation with heat-inactivated Brucella abortus. Infect Immun 2001; 69: 3817-26.
14. Lucotte G. Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times. Hum Immunol 2001; 62: 933-6.
15. Marascuilo LA, McSweeney M. Nonparametric and distribution-free methods for the social sciences. Monterey, CA: Brooks/Cole; 1977. p. 556.
16. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons, 1981. p. 321.
17. Meyer L, Magierowska M, Hubert JB, et al. CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups. J Infect Dis 1999; 180: 920-4.
18. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998; 102: 199-209.